Inhibition of HSP90β Improves Lipid Disorders by Promoting Mature SREBPs Degradation via the Ubiquitin-proteasome System
Zu‐Guo Zheng(China Pharmaceutical University), Xiaojun Xu(Guangdong Provincial People's Hospital), Xiao-Xiao Liu(China Pharmaceutical University), Xiuxiu Jin(Sichuan University), Weiliang Zhu(Chinese Academy of Sciences), Pyone Myat Thu(China Pharmaceutical University), Lunzhi Dai(Sichuan University), Xin Zhang(Academy of Military Medical Sciences), Yu Li(Boston University), Hui‐Jun Li(China Pharmaceutical University), Cheng Peng(Chinese Academy of Sciences), Chang Liu(China Pharmaceutical University), Lin Wang(Second Hospital of Tianjin Medical University), Ping Li(Nanjing Medical University), Hongyang Li(China Pharmaceutical University), Junli Liu(Shanghai Jiao Tong University), Mu Zhang(Nanjing Medical University), Huimin Cheng(China Pharmaceutical University), Ligong Chen(Sichuan University), Dan Jing(China Pharmaceutical University), Jing Zhu(Hangzhou First People's Hospital), Bin Xue(Nanjing University)
Cited by 82
Related Papers
A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information
|Nature Communications|2017|884
Protein Kinase C θ Inhibits Insulin Signaling by Phosphorylating IRS1 at Ser1101
|Journal of Biological Chemistry|2004|352
Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats
|Experimental & Molecular Medicine|2019|337
A deep learning framework for modeling structural features of RNA-binding protein targets
|Nucleic Acids Research|2015|267
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204